Transforming Genomics for drug discovery and precision medicine

We are a rare mix of geneticists, bioinformaticians and technology experts who work together to decode the whole genome. We have developed Lucid to make cutting edge AI driven analysis easily available for researchers and clinicians.

Explore our LinkedIn

Our mission

We decode the full potential of the human genome, extracting 100% of DNA data with unprecedented precision and accuracy.

Our vision

We empower researchers, clinicians, and innovators to unlock discoveries, accelerate personalized treatments, and shape a healthier future. Every genome tells a story, and our technology ensures no detail is left unheard.

Meet the Team

  • Dr. Uirá Souto Melo

    Co-founder & CEO

    Ph.D in Genetics and expert in the "dark genome" -an unexplored region of the genome that hides secrets about health and disease.

    Explore his LinkedIn

  • Dr. M-Hossein Moeinzadeh

    Co-founder & CTO

    Ph.D. in Computational Biology with expertise in detecting and interpreting human genome variations.

    Explore his LinkedIn

  • Achim Geppert

    Co-founder & CCO

    M.Sc in International Business with a strong track record in building and scaling digital solutions in the life science industry.

    Explore his LinkedIn

  • Dr. Jakob Hertzberg

    Head of Technology

    in

  • Nico Alavi

    Machine Learning Scientist

    in

  • Hessam Khoshniat

    Principal Software Engineer

    in

  • Mojtaba Niazi

    Software Engineer

    in

  • Lion Ward Al Raei

    Data Scientist

    in

  • Tessa Remmers

    Founders Associate

    in

Advisors

  • Prof. Dr. Stefan Mundlos

    Former director of the Institute for Medical and Human Genetics at Charité

  • Prof. Dr. Martin Vingron

    Director of the Max Planck Institute for Molecular Genetics

  • Dr. Bertram Weiss

    As former Head of Bioinformatics at Bayer, Bertram is our independent scientific advisor.

Our Licensing Partners & Collaborators

Our story

Interested in joining us?

Reach out to explore opportunities to collaborate with Lucid Genomics.